AHCC and Chemotherapy: Reducing Side Effects in Cancer Patients
- People are treated with drugs designed to kill cancer cells, but unfortunately these drugs also destroy healthy cells sometimes causing serious side effects.
- Of the common side effects associated with chemotherapy, one has the potential to be very serious: neutropenia or a low white blood cell count.
- White blood cells fight infections and if a patient’s levels drop too low, they may need to stop their chemotherapy for a while. This places the patient at an increased risk for infections and also interrupts their cancer treatment.
- Along with this major side effect, there are a number of other serious side effects to be aware of. They are discussed in detail in Chapter 5 of The Patient’s Guide to AHCC.
Hair Loss and Chemotherapy
Nausea, Vomiting and Chemotherapy
- Nausea and vomiting can be so severe for some patients that they decide to stop undergoing chemotherapy.
- Recent clinical studies and case reports show that AHCC can improve patient quality of life regarding nausea and vomiting. One study in particular noted that patients taking AHCC found an improvement in the nausea, vomiting, and pain during their cancer treatment than they experienced prior to supplementation.
Impaired Liver, Spleen Function and Chemotherapy
Myelosuppression and Chemotherapy
- Bone marrow is vital in the creation of white blood cells, red blood cells and platelets – when bone marrow is damaged by chemotherapy the production and levels of these critical immune system substances declines. This makes patients highly susceptible to infections and they can also develop anemia, which exacerbates their lowered resistance.
- Multiple studies show that AHCC can have a positive effect on myelosuppression and improve white blood cell levels in response to chemotherapy.
- The ability of AHCC to mitigate myelosuppresion and to enhance immune cell activity and function are critically important benefits for individuals who experience a decline in white blood cell levels as a result of chemotherapy, as well as a potential way to reduce the risks associated with this life-threatening complication.